In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 141-30-0, name is 3,6-Dichloropyridazine, introducing its new discovery. Application In Synthesis of 3,6-Dichloropyridazine
SUBSTITUTED TRIAZOLO-PYRIDAZINE DERIVATIVES
This invention relates to novel substituted triazolo-pyridazines, their derivatives, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering an alpha1 -GABA-A receptor antagonist and/or a alpha2, alpha3 and alpha5 GABA-A receptor agonist.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 141-30-0, and how the biochemistry of the body works.Application In Synthesis of 3,6-Dichloropyridazine
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1334 – PubChem